CIPLA CINACALCET cinacalcet (as hydrochloride) 90 mg tablet bottle

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

cinacalcet hydrochloride, Quantity: 99.191 mg (Equivalent: cinacalcet, Qty 90 mg)

Prieinama:

Cipla Australia Pty Ltd

Vaisto forma:

Tablet, film coated

Sudėtis:

Excipient Ingredients: microcrystalline cellulose; pregelatinised starch; crospovidone; povidone; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake

Vartojimo būdas:

Oral

Vienetai pakuotėje:

28's

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

Cipla Cinacalcet may be used to treat the biochemical manifestations of secondary hyperparathyroidism (HPT) in patients with end stage renal disease, receiving dialysis (see section 5.1 Pharmacodynamic properties, Clinical trials). Cipla Cinacalcet should be used as adjunctive therapy.,Cipla Cinacalcet is indicated for the treatment of hypercalcaemia in patients with parathyroid carcinoma.,Cipla Cinacalcet may be used to treat the biochemical manifestations of primary HPT in patients for whom parathyroidectomy is not a treatment option.

Produkto santrauka:

Visual Identification: Light green coloured, oval shaped, biconvex film-coated tablets, debossed with "CL" on one side and "412" on other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizacija statusas:

Registered

Leidimo data:

2023-02-07